Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada

Journal of the National Cancer Institute

Volumn 89, Issue 3, 1997, Pages 251-256

  Tarone, Robert E ^a,c   Chu, Kenneth C ^a   Gaudette, Leslie A ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HEALTH STATISTICS DIVISION   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; RACE DIFFERENCE; UNITED STATES;

EID: 0031037428     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.3.251     Document Type: Article

References (32)

1. Blot WJ, Fraumeni JF Jr, Stone BJ. Geographic patterns of breast cancer in the United States. J Natl Cancer Inst 1977;59:1407-11.
2. Pickel LW, Mason TJ, Howard N, Hoover R, Fraumeni JF Jr. Atlas of U.S. cancer mortality among whites: 1950-1980. Bethesda (MD): National Institutes of Health; DHHS Publ No. (NIH)87-2900.
3. Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 1991;41:146-65.
4. Sturgeon SR, Schairer C, Gail M, McAdams M, Brinton LA, Hoover RN. Geographic variability in mortality from breast cancer among white women in the United States. J Natl Cancer Inst 1995;87:1846-53.
5. National Cancer Institute of Canada. Canadian Cancer Statistics 1993. Toronto: National Cancer Institute of Canada, 1993:55-65.
6. Miller BA, Ries LA, Hankey BF, Kosary CL, Harras A, Devesa SS, et al. SEER Cancer Statistics Review 1973-1990. Bethesda (MD): National Institutes of Health: DHHS Publ No. (NIH)93-2789: IV.1-IV.24.
7. MacMahon B. Cohort fertility and increasing breast cancer incidence. Cancer 1958;11:250-4.
8. Stevens RG, Moolgavkar SH, Lee JA. Temporal trends in breast cancer. Am J Epidemiol 1982;115:759-77.
9. Blot WJ, Devesa SS, Fraumeni JF Jr. Declining breast cancer mortality among young American women. J Natl Cancer Inst 1987;78: 451-4.
10. Holford TR, Roush GC, McKay LA. Trends in female breast cancer in Connecticut and the United States. J Clin Epidemiol 1991;44:29-39.
11. Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 1992;84:1402-10.
12. Tarone RE, Chu KC. Evaluation of birth cohort patterns in population disease rates. Am J Epidemiol 1996;143:85-91.
13. Grace MG, Gaudette LA, Burns PE. The increasing incidence of breast cancer in Alberta 1953-1973. Cancer 1977;40:358-63.
14. Gaudette LA, Silberberger C, Altmayer CA, Gao RN. Trends in breast cancer incidence and mortality. Statistics Canada Catalog 82-003 (quarterly), Health Reports 1996;8:29-37.
15. Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics 1983; 39:311-24.
16. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-period and age-cohort models. Stat Med 1987;6:449-67.
17. McCullagh P, Neider JA. Generalized linear models. New York: Chapman and Hall, 1989: 126-8.
18. Boice JD Jr, Mandel JS, Doody MM. Breast cancer among radiologic technologists. JAMA 1995;274:394-401.
19. Chu KC, Tarone RE, Kessler LG, Ries LA, Hankey BF, Miller BA, et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996;88: 1571-9.
20. Boyle P, Robertson C. Breast cancer and colon cancer incidence in females in Scotland, 1960-1984. J Natl Cancer Inst 1987;79:1175-9.
21. Velentgas P, Daling JR. Risk factors for breast cancer in younger women. Monogr Natl Cancer Inst 1994;16:15-24.
22. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1996;347:1713-27.
23. Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 1995;87: 827-35.
24. Beral V, Hermon C, Reeves G, Key T. Breast cancer trends in women in Sweden, the UK and the USA in relation to their past use of oral contraceptives. In: Li JJ, Li SA, Nandi A, Gustafsson JA, editors. Proceedings of the Second International Symposium on Hormonal Carcinogenesis. Berlin: Springer-Verlag, 1996:99-106.
25. Brind J, Chinchilli VM, Severs WB, Summy-Long J. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health 1996;50:481-96.
26. Daling JR, Brinton LA, Voight LF, Weiss NS, Coates RJ, Malone KE, et al. Risk of breast cancer among white women following induced abortion. Am J Epidemiol 1996;144:373-80.
27. Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Willett WC. Pregnancy termination in relation to risk of breast cancer. JAMA 1996;275:283-7.
28. White EW, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82:1546-52.
29. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst 1991;83:1540-6.
30. Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 1991;2:67-74.
31. Beral V, Hermon C, Reeves G, Peto R. Sudden fall in breast cancer death rates in England and Wales [letter]. Lancet 1995;345:1642-3.
32. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries. Br Med J 1995;311:1391-5.